Aptinyx Inc reported $6.28M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Biogen BIIB:US $ 4211.6M 864.4M
Cara Therapeutics CARA:US $ 15.53M 358K
Daiichi Sankyo 4568:JP Y 336046M 3275M
Eli Lilly And LLY:US $ 13682M 1411.2M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Marinus Pharmaceuticals MRNS:US $ 37.68M 20.98M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NOVN:VX SF 29880M 247M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M